Tag: Dea classification

According to the U.S. Drug Enforcement Administration (DEA), paraldehyde is classified as a Schedule IV controlled substance, indicating a lower potential for abuse compared to Schedule III drugs. This synthetic central nervous system depressant was once a widely-used sedative and hypnotic but has largely been replaced by safer and more effective modern medications.

According to the 2023 National Survey on Drug Use and Health, 2 million people misused codeine products, highlighting its significant potential for abuse. To prevent misuse, regulations have been established, and understanding what schedule is codeine considered is crucial for patients, prescribers, and pharmacists. Its classification is not static but varies depending on the product's composition and concentration.